Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02514382 · COMPLETED
Trial details
- NCT number
- NCT02514382
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-21
- Primary completion
- 2022-04-19
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.